Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novocure Ltd Ord Sh (NQ: NVCR ) 14.72 +0.18 (+1.24%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Novocure Ltd Ord Sh < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Novocure Announces Presentations on Tumor Treating Fields Therapy, Including New Clinical Data and Real-World Evidence, at 2023 Society for Neuro-Oncology Annual Meeting November 10, 2023 From Novocure Via Business Wire Is Novocure Stock a Buy? November 03, 2023 The stock isn't far from its 52-week low. Via The Motley Fool Why Novocure Stock Was Sick Today October 26, 2023 Investors weren't particularly pleased with the company's third-quarter performance. Via The Motley Fool NovoCure (NVCR) Q3 2023 Earnings Call Transcript October 26, 2023 NVCR earnings call for the period ending September 30, 2023. Via The Motley Fool Topics Earnings Exposures Financial Novocure Reports Third Quarter 2023 Financial Results October 26, 2023 From Novocure Via Business Wire Why Novocure Stock Fell 24.4% This Week August 31, 2023 Novocure announced a disappointing outcome from a phase 3 clinical trial for a key cancer treatment. Via The Motley Fool What 11 Analyst Ratings Have To Say About NovoCure August 29, 2023 Via Benzinga Novocure Announces Presence at European Society for Medical Oncology (ESMO) Congress 2023 October 15, 2023 From Novocure Via Business Wire Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program October 12, 2023 From Novocure Via Business Wire NovoCure Limited (NASDAQ:NVCR) Long Term Shareholder Notice: Investigation of Potential Wrongdoing October 10, 2023 San Diego, CA -- (SBWIRE) -- 10/10/2023 -- An investigation was announced for investors in shares of NovoCure Limited (NASDAQ:NVCR) concerning potential breaches of fiduciary duties by certain... Via SBWire Why NovoCure Stock Is Crashing Today August 28, 2023 The company disappointed investors with its latest clinical trial update. Via The Motley Fool 10 Health Care Stocks Whale Activity In Today's Session October 05, 2023 Via Benzinga Novocure to Report Third Quarter 2023 Financial Results October 02, 2023 From Novocure Via Business Wire Novocure Announces Presence at American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting September 29, 2023 From Novocure Via Business Wire Stocks That Hit 52-Week Lows On Friday September 29, 2023 Friday's session saw 112 companies set new 52-week lows. Via Benzinga 3 Things About NovoCure That Smart Investors Know September 19, 2023 Its cancer-treating device is struggling to find its market. Via The Motley Fool Novocure Highlights Use of Tumor Treating Fields Therapy in Treatment of Non-Small Cell Lung Cancer at 2023 World Conference on Lung Cancer September 08, 2023 From Novocure Via Business Wire 3 Healthcare Stocks to Sell in September Before They Crash & Burn September 06, 2023 The prognosis for these healthcare stocks isn't optimistic so plan to sell them this month before they get worse. Via InvestorPlace Down 31% in 1 Day, What's Next for NovoCure Stock? September 04, 2023 It's entering a risky period, but it could persevere. Via The Motley Fool Is NovoCure's Stock Headed for a Free Fall? August 31, 2023 It can be hard to find a reason to remain bullish on NovoCure. Via The Motley Fool Novocure Announces The Lancet Oncology Publishes Primary Data from Phase 3 LUNAR Clinical Trial in Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies August 29, 2023 From Novocure Via Business Wire Stocks That Hit 52-Week Lows On Tuesday August 29, 2023 On Tuesday, 99 stocks hit new 52-week lows. Via Benzinga What's Going On With NovoCure Stock Today? August 29, 2023 NovoCure Limited (NASDAQ: NVCR) shares are trading higher Tuesday. The stock appears to be recovering from a loss of over 30% on Monday. What To Know: Via Benzinga PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday August 29, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Dow Gains Over 100 Points; Hawaiian Electric Shares Surge August 28, 2023 U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Monday. The Dow traded up 0.42% to 34,490.80 while the NASDAQ rose 0.62% to 13,674.49. The S&P 500,... Via Benzinga Topics Stocks Exposures US Equities Why Is Novocure (NVCR) Stock Down 30% Today? August 28, 2023 Following Novocure’s disappointing late-stage clinical trial for its cancer-treating platform, NVCR stock stumbled on relevancy concerns. Via InvestorPlace Why Is Cancer Focused-Novocure's Stock Plunging Today? August 28, 2023 Novocure Ltd (NASDAQ: NVCR) shares are falling after the company's phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 clinical trial of Tumor Treating Fields (TTFields) together with paclitaxel in patients... Via Benzinga Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session August 28, 2023 Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 28, 2023 Via Benzinga Crude Oil Rises; GD Culture Group Shares Spike Higher August 28, 2023 U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 150 points on Monday. The Dow traded up 0.46% to 34,505.54 while the NASDAQ rose 0.43% to 13,649.27. The S&P 500, also... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.